Table 1.
ATLL | Asymptomatic HTLV-1 Carrier | Healthy control | ||
---|---|---|---|---|
Number of subjects | 11 | 37 | 20 | |
Disease type | Acute | 2 | – | |
Lymphoma | 0 | – | – | |
Chronic | 1 | – | – | |
Smoldering | 8 | – | – | |
High-risk carrier | – | 8 | – | |
Low-risk carrier | – | 29 | – | |
Age | 67.4 ± 5.1 | 60.6 ± 10.4 | 58.6 ± 3.0 | |
Sex (F/M) | 4:7 | 28:9 | 0:20 | |
PVL (/1000PBMC) | 243.0 ± 274.6 | 60.6 ± 91.3 | – | |
sIL-2Ra(U/mL) | 2564.8 ± 4357.5 | 450.1 ± 146.3 | – | |
Chemotherapy prior to blood sampling | 1 | 1 | – | |
Chemotherapy prior to stool sampling | 1 | 1 | 0 | |
Antibiotics prior to blood sampling | 2 | 4 | – | |
Antibiotics prior to stool sampling | 2 | 4 | 4 |